Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies.
Business Segments
The company operates through two segments Ypsomed Delivery System…
Analysis
Hope premium
Ypsomed Holding AG is priced well ahead of what the underlying numbers justify, a pattern we describe as a hope premium. Worth noting: the cash the business generates has lagged behind what the income statement shows.
Valuation data is not available for this company.
Growth is tepid; the safety picture is adequate. The company scores 8/20 on our value-creation score: creating some value.
Flags to be aware of: Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.
360° rank · history
1007550250
Jan 202331
20
2023202420252026
All-time high
77
Jan 2025
All-time low
20
Jun 2026
Average rank
50
across all years
Detailed & Historical Ranks
Deep dive into 15 detailed ranks and 3 years of history.
Current202520242023
Price/Sales
12
7
12
46
Price/Earnings
12
26
14
18
Price/Book
26
6
9
36
Dividend Yield
61
54
47
39
Value (overall)
26
16
7
15
Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.